DEBRA CALABRESE: Open Payments
NPI 1124206750 · WESTLAKE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 66 payments from 11 companies in 2025. Trend: 2023 $205 · 2024 $307 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $517 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $145 |
| Janssen Biotech, Inc. | 7 | $141 |
| Madrigal Pharmaceuticals | 2 | $50 |
| Gilead Sciences, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $21 |
Products named: RINVOQ, TREMFYA, ENTYVIO, SKYRIZI, CREON, REZDIFFRA, XELJANZ, OMVOH.
Industry payments across OH — which companies pay providers there.
